Back to Journals » Therapeutics and Clinical Risk Management » Volume 11
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Real-world analysis of the Celgene Global Drug Safety database: early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rash
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
17,618 | Dovepress* | 16,294+ | 1,514 | 17,808 | |
PubMed Central* | 1,324 | 334 | 1,658 | ||
Totals | 17,618 | 1,848 | 19,466 | ||
*Since 4 September 2015 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
8 | 1 | 0 | 0 | 3 | 4 |
View citations on PubMed and Google Scholar